<![CDATA[Male breast cancer accounts for less than 1% of all breast malignancies, yet its incidence has been rising in recent years. Because clinicians rarely suspect the diagnosis in men, presentation is frequently delayed and outcomes tend to be worse than in women. We report a case illustrating how this delay can unfold in practice, along with the multidisciplinary approach required once advanced disease is confirmed. A 62-year-old man presented with a one-year history of a right breast mass that had progressed to a chronic, ulcerated wound with yellowish discharge and intermittent bleeding. Breast ultrasonography identified the lesion as BI-RADS 5. Additionally, a chest radiograph indicated possible pulmonary metastasis. Histopathology confirmed invasive ductal carcinoma, non-special type, with invasive lobular differentiation grade III and nuclear pleomorphism grade II. The case highlights two recurring problems in male breast cancer: patients and primary-care providers alike tend to attribute early symptoms to benign causes, and formal screening pathways for men simply do not exist. By the time malignancy is confirmed, disease is often locally advanced or metastatic, as seen here. Management therefore had to combine palliative wide excision for local symptom control with systemic therapy guided by receptor status. Although rare, male breast cancer warrants the same clinical vigilance given to female patients presenting with a breast lump. Earlier recognition, paired with individualized and multidisciplinary treatment, including palliative care where indicated, remains the most realistic route to better outcomes.]]>
Copyrights © 2026
